Sharon Barr

Executive Vice-President, BioPharmaceuticals R&D

AstraZeneca PLC

Pharmaceutical Executive, Research & Development Executive

Sharon Barr is a pharmaceutical research and development executive serving as Executive Vice-President, BioPharmaceuticals R&D at AstraZeneca. She was appointed to the role in August 2023 and is responsible for discovery through late-stage development across AstraZeneca's Cardiovascular, Renal & Metabolism and Respiratory & Immunology areas. Barr joined AstraZeneca in 2013 and previously served as Senior Vice-President and Head of Research and Product Development at Alexion, AstraZeneca Rare Disease. Her career spans pharmaceutical research, development and leadership, with extensive experience in advancing medicines from scientific discovery through clinical development.